A Study of Adalimumab to Treat Sarcoidosis of the Skin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00274352|
Recruitment Status : Completed
First Posted : January 10, 2006
Last Update Posted : May 22, 2013
Pariser, Robert J., M.D.
Virginia Clinical Research, Inc.
Information provided by (Responsible Party):
Robert J. Pariser, MD, Virginia Clinical Research, Inc.
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||February 2012|
|Actual Study Completion Date :||February 2012|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
October 28, 2016 ||December 21, 2016|